Maze Therapeutics
IPOHarnessing the power of genetics to transform the lives of patients
Public · South San Francisco, United States · Founded 2020 · $190.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2020
- Business Model
- Other
- Website
- mazetx.com
- Total Funding
- $190.0M
- Last Round
- $190.0M Venture RoundJan 2022
- Rounds
- 1
- Type
- Public
About
Maze Therapeutics is a clinical-stage biopharmaceutical company using human genetics insights via its Compass platform to develop small molecule precision medicines for kidney and metabolic diseases like APOL1-mediated kidney disease and chronic kidney disease.
Summary
Maze Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2020. It has raised $190.0M in total across 1 round, most recently a $190.0M Venture Round round in Jan 2022. Investors include Matrix Capital Management and Andreessen Horowitz.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...